OneSource Specialty Pharma Limited (NSE:ONESOURCE)
1,592.00
+50.10 (3.25%)
Sep 11, 2026, 3:30 PM IST
NSE:ONESOURCE Revenue
OneSource Specialty Pharma had revenue of 4.49B INR in the quarter ending June 30, 2026, with 37.20% growth. This brings the company's revenue in the last twelve months to 15.43B, up 4.29% year-over-year. In the fiscal year ending March 31, 2026, OneSource Specialty Pharma had annual revenue of 14.23B, down -1.49%.
Revenue (ttm)
15.43B
Revenue Growth
+4.29%
P/S Ratio
11.83
Revenue / Employee
9.22M
Employees
1,674
Market Cap
182.54B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 14.23B | -215.98M | -1.49% |
| Mar 31, 2025 | 14.45B | 12.73B | 740.50% |
| Mar 31, 2024 | 1.72B | 1.33B | 344.07% |
| Mar 31, 2023 | 387.14M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
OneSource Specialty Pharma News
- 6 weeks ago - OneSource Specialty Pharma Transcript: Q1 26/27 - Transcripts
- 6 weeks ago - OneSource Specialty Pharma Quarterly report: Q1 2027 - Filings
- 6 weeks ago - OneSource Specialty Pharma Slides: Q1 2027 - Filings
- 4 months ago - OneSource Specialty Pharma Transcript: Q4 25/26 - Transcripts
- 4 months ago - OneSource Specialty Pharma Slides: Q4 2026 - Filings
- 4 months ago - OneSource Specialty Pharma Quarterly report: Q4 2026 - Filings
- 4 months ago - OneSource Specialty Pharma Annual report: Q4 2026 - Filings
- 7 months ago - OneSource Specialty Pharma Transcript: Q3 25/26 - Transcripts